AJMC July 29, 2024

Dr. Cannon discusses payers and PBMs making decisions about biosimilars in the commercial sector.

Video content above is prompted by the following:

  • How are payers and PBMs making decisions about...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Payer, Pharma / Biotech, Trends
A new era of Made in America drug manufacturing
Eli Lilly to invest $27B in manufacturing
Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More
AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch
AI accelerates discovery of neurodevelopmental disorder-associated genes

Share This Article